EU Drug Markets Report

The 2016 EU Drug Markets Report provides a unique insight into the operation of illicit drug markets in the EU. The report assesses the impact of the drug market on society and the factors driving it. It explores the market for cannabis, heroin, cocaine, amphetamines, MDMA and new psychoactive substances. Understanding these hidden markets, and the actors involved, is essential to making sound policy decisions with lasting impact. The report combines the analytical power of the EMCDDA’s drug monitoring system with Europol’s operational intelligence on trends in organised crime.#EDMR16

Download the report

About the package

Two separate publications cover the topic at different levels. The Strategic Overview is a 30-page summary offering easy access to the key findings of the main report. The In-depth Analysis is a comprehensive 188-page report, analysing what is known about the European drug market today.

Synthetic drug production explained

Motion graphics and infographics

Heroin production explained

Motion graphics and infographics

What are new psychoactive substances

Motion graphics and infographics

Herbal cannabis trafficking flows

Motion graphics and infographics

Cannabis resin trafficking flows

Motion graphics and infographics

Cocaine trafficking flows

Motion graphics and infographics

Heroin trafficking flows

Launch and press details

The 2016 EU Drug Markets Report — In-depth Analysis is being launched at a press conference in Brussels on 5 April by Dimitris Avramopoulos, European Commissioner for Migration, Home Affairs and Citizenship. The Commissioner will be joined by EMCDDA Director Alexis Goosdeel and Europol Director Rob Wainwright.